Literature DB >> 20685690

Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.

Hiroe Sato1, Felix A Woodhead, Tariq Ahmad, Jan C Grutters, Paolo Spagnolo, Jules M M van den Bosch, Lisa A Maier, Lee S Newman, Sonoko Nagai, Takateru Izumi, Athol U Wells, Roland M du Bois, Kenneth I Welsh.   

Abstract

The HLA class II (DRB1 and DQB1) associations with sarcoidosis have been studied by several groups but often without consistent results. In this paper, we consider the hypothesis that observed inconsistencies relate to distinct, genetically encoded disease phenotypes which differ in prevalence between centres. We therefore typed HLA-DRB1 and DQB1 in 340 UK, 139 Dutch and 163 Japanese sarcoidosis patients and, respectively, 354, 218 and 168 healthy controls from these populations. We applied consistent phenotyping and genotyping and investigated associations between HLA class II alleles and distinct disease phenotypes within and between ethnic groups. DRB1*01 and DQB1*0501 are protective against all manifestations of sarcoidosis. Lung-predominant sarcoidosis is associated with DRB1*12 and *14. Löfgren's syndrome is a common sarcoidosis phenotype in the Dutch and is strongly associated with the DRB1*0301 allele. This phenotype is not seen among the Japanese in whom DRB1*0301 is absent. The same allele is protective for UK uveitis. Sarcoid uveitis is common in Japan. The DRB1*04-DQB1*0301 haplotype is a risk factor for this disease manifestation in Japanese and UK subjects but protective for sarcoidosis overall. We show that distinct sarcoidosis phenotypes have similar genetic associations across ethnic groups. The disease case mix differs between centres and may be explained by different ethnic allelic frequencies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685690      PMCID: PMC4351376          DOI: 10.1093/hmg/ddq325

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  45 in total

1.  SKDM human leukocyte antigen (HLA) tool: A comprehensive HLA and disease associations analysis software.

Authors:  Stathis Kanterakis; Eleni Magira; Kenneth D Rosenman; Milton Rossman; Keyur Talsania; Dimitri S Monos
Journal:  Hum Immunol       Date:  2008-07-02       Impact factor: 2.850

2.  Sarcoidosis is associated with a truncating splice site mutation in BTNL2.

Authors:  Ruta Valentonyte; Jochen Hampe; Klaus Huse; Philip Rosenstiel; Mario Albrecht; Annette Stenzel; Marion Nagy; Karoline I Gaede; Andre Franke; Robert Haesler; Andreas Koch; Thomas Lengauer; Dirk Seegert; Norbert Reiling; Stefan Ehlers; Eberhard Schwinger; Matthias Platzer; Michael Krawczak; Joachim Müller-Quernheim; Manfred Schürmann; Stefan Schreiber
Journal:  Nat Genet       Date:  2005-02-27       Impact factor: 38.330

3.  Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69.

Authors:  M Amicosante; N Sanarico; F Berretta; J Arroyo; G Lombardi; R Lechler; V Colizzi; C Saltini
Journal:  Hum Immunol       Date:  2001-07       Impact factor: 2.850

4.  Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis.

Authors:  P J Foley; D S McGrath; E Puscinska; M Petrek; V Kolek; J Drabek; P A Lympany; P Pantelidis; K I Welsh; J Zielinski; R M du Bois
Journal:  Am J Respir Cell Mol Biol       Date:  2001-09       Impact factor: 6.914

5.  Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians.

Authors:  Surendra K Sharma; Arumugam Balamurugan; Ravindra M Pandey; Pradip Kumar Saha; Narinder K Mehra
Journal:  Am J Respir Cell Mol Biol       Date:  2003-02-14       Impact factor: 6.914

6.  HLA-DQB1 0602 allele is associated with splenomegaly in Japanese sarcoidosis.

Authors:  H Sato; S Nagai; R M du Bois; T Handa; Y Suginoshita; K Ohta; K I Welsh; T Izumi
Journal:  J Intern Med       Date:  2007-10       Impact factor: 8.989

7.  Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis.

Authors:  Jan C Grutters; Hiroe Sato; Panagiotis Pantelidis; Henk J T Ruven; Deirdre S McGrath; Athol U Wells; Jules M M van den Bosch; Kenneth I Welsh; Roland M du Bois
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2003-03       Impact factor: 0.670

8.  Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis.

Authors:  David R Karp; Nishanth Marthandan; Steven G E Marsh; Chul Ahn; Frank C Arnett; David S Deluca; Alexander D Diehl; Raymond Dunivin; Karen Eilbeck; Michael Feolo; Paula A Guidry; Wolfgang Helmberg; Suzanna Lewis; Maureen D Mayes; Chris Mungall; Darren A Natale; Bjoern Peters; Effie Petersdorf; John D Reveille; Barry Smith; Glenys Thomson; Matthew J Waller; Richard H Scheuermann
Journal:  Hum Mol Genet       Date:  2009-11-18       Impact factor: 6.150

9.  Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis.

Authors:  P Spagnolo; H Sato; J C Grutters; E A Renzoni; S E Marshall; H J T Ruven; A U Wells; A Tzouvelekis; C H M van Moorsel; J M M van den Bosch; R M du Bois; K I Welsh
Journal:  Tissue Antigens       Date:  2007-09

10.  HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis.

Authors:  Hiroe Sato; Jan C Grutters; Panagiotis Pantelidis; A Neil Mizzon; Tariq Ahmad; Arend-Jan Van Houte; Jan-Willem J Lammers; Jules M M Van Den Bosch; Kenneth I Welsh; Roland M Du Bois
Journal:  Am J Respir Cell Mol Biol       Date:  2002-10       Impact factor: 6.914

View more
  32 in total

1.  Early prediction of sarcoidosis prognosis with HLA typing: a 5 year follow-up study.

Authors:  Ezgi Ozyilmaz; Ozlem Goruroglu Ozturk; Ali Durmaz; Orhan Othman Hasan; Bugra Guzelbaba; Gulsah Seydaoglu; Sedat Kuleci; Ismail Hanta; Eren Erken; Ali Kocabas
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  Familial sarcoidosis: Report of a mother and her son.

Authors:  Ekin Akyıldız; Şenol Kobak
Journal:  Eur J Rheumatol       Date:  2017-10-25

3.  Association of class II human leukocyte antigen (HLA) alleles with pulmonary sarcoidosis.

Authors:  Dorina Esendagli; Fusun Ozmen; Deniz Koksal; Sevgen Onder; Salih Emri
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 4.  Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.

Authors:  Johan Grunewald; Paolo Spagnolo; Jan Wahlström; Anders Eklund
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 5.  Granuloma genes in sarcoidosis: what is new?

Authors:  Annegret Fischer; Benjamin A Rybicki
Journal:  Curr Opin Pulm Med       Date:  2015-09       Impact factor: 3.155

6.  Association of HLA-DRB1 with Sarcoidosis Susceptibility and Progression in African Americans.

Authors:  Albert M Levin; Indra Adrianto; Indrani Datta; Michael C Iannuzzi; Sheri Trudeau; Jia Li; Wonder P Drake; Courtney G Montgomery; Benjamin A Rybicki
Journal:  Am J Respir Cell Mol Biol       Date:  2015-08       Impact factor: 6.914

Review 7.  Etiologies of Sarcoidosis.

Authors:  Edward S Chen; David R Moller
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

8.  DNA Methylation Changes in Lung Immune Cells Are Associated with Granulomatous Lung Disease.

Authors:  Ivana V Yang; Iain Konigsberg; Kristyn MacPhail; Li Li; Elizabeth J Davidson; Peggy M Mroz; Nabeel Hamzeh; May Gillespie; Lori J Silveira; Tasha E Fingerlin; Lisa A Maier
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

Review 9.  Idiopathic giant cell myocarditis and cardiac sarcoidosis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

10.  Genome-Wide Association Study of Ocular Sarcoidosis Confirms HLA Associations and Implicates Barrier Function and Autoimmunity in African Americans.

Authors:  Lori Garman; Nathan Pezant; Ambra Pastori; Kathryn A Savoy; Chuang Li; Albert M Levin; Michael C Iannuzzi; Benjamin A Rybicki; Indra Adrianto; Courtney G Montgomery
Journal:  Ocul Immunol Inflamm       Date:  2020-03-06       Impact factor: 3.070

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.